CPD, or Carboxypeptidase D, is an enzyme belonging to the carboxypeptidase family. Carboxypeptidases are proteases that cleave amino acid residues from the C-terminal end of proteins and peptides. CPD, specifically, is a metallo-carboxypeptidase, which means it requires a metal ion, usually zinc, for its catalytic activity. Located in the trans-Golgi network, CPD plays an essential role in protein processing, particularly in the maturation of peptide hormones and neuropeptides. By cleaving off basic amino acids from these precursor proteins, CPD helps generate the mature, biologically active forms of these signaling molecules. Given its central role in the production of such signaling peptides, the regulation and activity of CPD are vital for proper cellular communication and overall physiological homeostasis.
Inhibitors targeting CPD would be molecules specifically designed to modulate the enzyme's catalytic activity. By inhibiting CPD, one could potentially impact the processing and maturation of a wide array of peptide hormones and neuropeptides, leading to altered signaling dynamics within the organism. Potential CPD inhibitors might be small molecules that directly bind to the enzyme's active site, preventing substrate access and thus inhibiting catalysis. These molecules could be designed to mimic the enzyme's natural substrates or to bind to crucial residues in the enzyme's active site. Another avenue for inhibition could involve molecules that bind to allosteric sites on CPD, altering its conformation and thereby its activity. Additionally, molecules that interfere with the enzyme's metal ion binding could also serve as effective inhibitors. Studying the effects of CPD inhibition can offer a deeper understanding of its role in peptide processing, its contributions to cellular signaling, and the broader implications of modulating peptide hormone and neuropeptide levels within an organism. Such insights can also inform the broader understanding of protein processing pathways and their regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin is a protease inhibitor that might inhibit CPD by blocking its enzymatic activity. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
Phosphoramidon inhibits various metalloproteases, and might affect CPD function. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 inhibits cysteine proteases, and while CPD is not a cysteine protease, off-target effects are possible. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is a general protease inhibitor, which could potentially inhibit CPD activity. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF is a broad-spectrum serine protease inhibitor, which could potentially affect CPD. | ||||||
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $32.00 | ||
A metal chelating agent that can inhibit metalloproteases, potentially impacting CPD. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A broad-spectrum protease inhibitor, which could potentially inhibit CPD activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomal degradation and could indirectly affect CPD levels or activity. | ||||||
Phenylmethylsulfonyl Fluoride | 329-98-6 | sc-3597 sc-3597A | 1 g 100 g | $50.00 $697.00 | 92 | |
PMSF is a serine protease inhibitor, which could potentially affect CPD activity. | ||||||